Chandra Bhagat Pharma Limited (BOM:542934)
India flag India · Delayed Price · Currency is INR
63.00
+3.00 (5.00%)
At close: Nov 16, 2026

Chandra Bhagat Pharma Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
2.431.116.6549.6464.456.81
Short-Term Investments
19.8716.691.371.321.12.21
Cash & Short-Term Investments
22.2747.798.0250.9765.4959.03
Cash Growth
-13.43%495.91%-84.26%-22.18%10.96%109.23%
Accounts Receivable
413.73546.17359.46394.4781.86150.04
Other Receivables
-0.212.292.620.950.71
Receivables
560.61550.78363.97533.84129.66192.54
Inventory
10.5546.726.9286.77290.77341.57
Prepaid Expenses
-0.39-1.080.30.07
Other Current Assets
25.38231.02567.6306.5494.67114.06
Total Current Assets
618.8876.7946.5979.18580.9707.26
Property, Plant & Equipment
39.8926.2426.2225.227.284.73
Long-Term Deferred Tax Assets
2.21.730.690.21--
Long-Term Deferred Charges
-2.184.376.559.5912.63
Other Long-Term Assets
5.7635.2137.526.898.07-
Total Assets
666.65942.061,0151,018605.83724.62

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
106.78318.8589.53132.3131.0226.72
Accrued Expenses
-2.971.942.249.0210.42
Short-Term Debt
-134.01180.52140.58137.39143.85
Current Portion of Long-Term Debt
132.565.385.259.5612.7813.12
Current Income Taxes Payable
-11.624.016.032.932.71
Other Current Liabilities
51.37111.99411.25419.8776.33183.7
Total Current Liabilities
290.72584.82692.49710.6269.48380.52
Long-Term Debt
17.9725.6822.8414.1339.2854.2
Long-Term Deferred Tax Liabilities
----0.140.12
Other Long-Term Liabilities
0.290.290.293.2322.1623.03
Total Liabilities
308.98610.79715.61727.96331.05457.87

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
75.4575.4575.4575.4575.4575.45
Additional Paid-In Capital
-133.71133.71133.71-133.71
Retained Earnings
-122.190.5380.93-57.6
Comprehensive Income & Other
282.22---199.34-0
Shareholders' Equity
357.68331.27299.69290.09274.79266.76
Total Liabilities & Equity
666.65942.061,0151,018605.83724.62

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
150.53165.07208.6164.27189.45211.18
Net Cash (Debt)
-128.27-117.28-200.58-113.3-123.95-152.15
Net Cash Growth
------
Net Cash Per Share
-17.09-15.54-26.58-15.02-16.43-20.17
Filing Date Shares Outstanding
7.557.557.557.557.557.55
Total Common Shares Outstanding
7.557.557.557.557.557.55
Working Capital
328.08291.87254.02268.58311.42326.75
Book Value Per Share
47.4043.9039.7238.4536.4235.35
Tangible Book Value
357.68331.27299.69290.09274.79266.76
Tangible Book Value Per Share
47.4043.9039.7238.4536.4235.35
Land
-2.742.742.742.742.74
Machinery
-45.1735.9631.248.424.76